Successful Immunotherapy of Murine Experimental Hepatic Metastases with Lymphokine-activated Killer Cells and Recombinant Interleukin 2

Cancer Research

Volumn 45, Issue 8, 1985, Pages 3735-3741

  Lafreniere, Rene ^a   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; INTERLEUKIN 2;

ANIMAL MODEL; CANCER IMMUNOTHERAPY; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; LIVER METASTASIS; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; THERAPY;

ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNIZATION, PASSIVE; IMMUNOTHERAPY; INTERLEUKIN-2; KILLER CELLS; LIVER NEOPLASMS, EXPERIMENTAL; LYMPHOKINES; MICE; MICE, INBRED C57BL; SPLEEN; WHOLE-BODY IRRADIATION;

EID: 0021969312     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Borberg, H., Oettgen, H. F., Choudry, K., and Beattie, E. J. Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors. Int. J. Cancer, 10: 539–547,1972.
2. Smith, H. G., Harmel, R. P. Hanna, M. G., Zwilling, B. S., Zbar, B., and Rapp, H. J. Regression of established intradermal tumors and lymph node metastases in guinea pigs after systemic transfer of immune lymphoid cells. J. Natl. Cancer Inst. 58:1315–1322,1977.
3. Grimm, E. A., Mazumder, A., Zhang, H. Z., and Rosenberg, S. A. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J. Exp. Med., 755; 1823–1841,1982.
4. Lotze, M. T., Grimm, E. A., Mazumder, A., Strausser, J. L., and Rosenberg, S. A. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res., 41: 4420–4425,1981.
5. Rosenstein, M., Yron, I., Kaufmann, Y., and Rosenberg, S. A. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2. Cancer Res., 44: 1946–1953,1984.
6. Yron, I., Wood, T. A., Spiess, P. J., and Rosenberg, S. A. In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors. J. Immunol., 125: 238–245,1980.
7. Gillis, S., Ferm, M. M., Ou, WM and Smith, K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol., 120: 2027–2032,1978.
8. Morgan, D. A., Ruscettt, F. W., and Gallo, R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science (Wash. DC), 792: 1007–1008,1976.
9. Rosenberg, S. A., Grimm, E. A., McGrogan, M., Doyle, M., Kawasaki, E., Koths, K., and Mark, D. F. Biological activity of recombinant human interteukin-2 produced in Escherichia coli. Science (Wash. DC), 223:1412–1415,1984.
10. Mule, J. J., Shu, S., Schwarz, S. L., and Rosenberg, S. A. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interieukin-2. Science (Wash. DC), 225:1487–1489,1984.
11. Rosenberg, S. A., Mule, J. J., Shu, S., Spiess, P., Reichert, C. M., and Scharw, S. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high dose recombinant IL-2. J. Exp. Med., 767:1169–1188,1985.
12. Taniguchi, T., Matsui, H., Fujita, T., Takaoka, C., Kashima, N., Yoshimoto, R., and Hamuro, J. Structure and expression of a cloned c DNA for human interteukin-2. Nature (Lond.), 302: 305–309,1983.
13. Parker, G. A., and Rosenberg, S. A. Serologic identification of multiple tumor-associated antigens on murine sarcomas. J. Natl. Cancer Inst., 58: 1303–1309,1977.
14. Chang, A. E., Hyatt, C. L., and Rosenberg, S. A. Systemic administration of recombinant human interteukin-2 in mice. J. Biol. Resp. Modif., 3: 561–572, 1984.
15. Donohue, J. H., and Rosenberg, S. A. The fate of interieukin-2 after in vivo administration. J. Immunol., 130: 2203–2208,1983.
16. Fekete, E. A comparative morphological study of the mammary gland in a high and a low tumor strain of mice. Am. J. Pathol., 14; 557–578,1938.
17. Gehan, E. A generalized Wilcoxon test for comparing arbitrarily single censored samples. Biometrika, 52: 203–223,1965.
18. Ettinghausen, S. E., Lipford, E. H., III., Mule, J. J., and Rosenberg, S. A. Systemic administration of recombinant interteukin-2 stimulates in vivo lymphoid cell proliferation in tissues. J. Immunol., in press, 1985.
19. Hougen, H. P., Hansen, F., Jensen, E. K., and Ropke, C. Kinetics of small lymphocytes in normal and nude mice after splenectomy. Scand. J. Haematol., 18: 257–266,1977.
20. Mule, J. J., Rosenstein, M., Shu, S., and Rosenberg, S. A. Eradication of a disseminated syngeneic lymphoma by systemic adoptive transfer of immune lymphocytes and its dependence upon a host components). Cancer Res., 45: 526–531,1985.
21. Shu, S., Fonseca, L. S., Kato, H., and Zbar, B. Mechanisms of immunological eradication of syngeneic guinea pig tumor. Participation of a components) of recipient origin in the expression of systemic adoptive immunity. Cancer Res., 43: 2637–2643,1983.
22. Mazumder, A., Eberiein, T. J., Grimm, E. A., Wilson, D. J., Keenan, A. M., Aamodt, R., and Rosenberg, S. A. Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells.Cancer (Phila.), 53:896–905,1984.
23. Thoman, M. L., and Weigle, W. O. Interteukin-2 induction of antigen-nonspecific suppressor cells. Cell. Immunol., 85: 215–224,1984.
24. Ting, C. C., Yang, S. S., and Hargrove, M. E. Induction of suppressor T cells by interteukin-2. J. Immunol., 133: 261–266,1984.
25. Small, M., and Trainin, N. Separation of populations of lymphoid cells into fractions inhibiting and fractions enhancing syngeneic tumor growth in vivo. J. Immunol., 117: 292–297,1976.